VNDA Vanda Pharmaceuticals Inc.: institutional ownership and insider trading
178 funds reported holding $339M of Vanda Pharmaceuticals Inc. in their latest 13F filings; in Q2 2026 funds net bought $17.3M, with 27 new positions and 25 funds selling out; over the last 12 months insiders bought $0 and sold $2.82M on the open market; over its last four quarters it reported revenue of $216M and net income of −$275M.
VNDA revenue and earnings
- Quarter ended Jun 30, 2026: revenue $50.5M, net income −$62.5M, EPS -1.04
- Quarter ended Mar 31, 2026: revenue $51.7M, net income −$48.6M, EPS -0.82
- Quarter ended Dec 31, 2025: revenue $57.2M, net income −$141M, EPS -2.40
- Quarter ended Sep 30, 2025: revenue $56.3M, net income −$22.6M, EPS -0.38
Famous investors holding VNDA
- Renaissance Technologies (Renaissance Technologies): $21.1M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $8.26M, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $9.81M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $5.20M, 0.0% of the portfolio
Largest institutional holders of VNDA
- BlackRock, Inc. (BLK) — $46.8M
- VANGUARD GROUP INC — $32.9M
- STATE STREET CORP (STT, STT-PG) — $21.5M
- AQR CAPITAL MANAGEMENT LLC — $21.4M
- RENAISSANCE TECHNOLOGIES LLC — $21.1M
- VANGUARD CAPITAL MANAGEMENT LLC — $15.4M
- AIGH Capital Management LLC — $12.5M
- ACADIAN ASSET MANAGEMENT LLC — $11.7M
- DIMENSIONAL FUND ADVISORS LP — $10.6M
- MILLENNIUM MANAGEMENT LLC — $9.81M
Recent VNDA insider trades
- Mar 2, 2026: Polymeropoulos Mihael Hristos sold 156,235 shares ($1.28M)
- Mar 2, 2026: Birznieks Gunther sold 42,431 shares ($351K)
- Mar 2, 2026: Williams Timothy sold 42,434 shares ($351K)
- Mar 2, 2026: Wijkstrom Joakim sold 30,800 shares ($255K)
5%+ owners
- Millennium Management LLC: 7.0% (Schedule 13G/A, filed Oct 9, 2026)
- AQR Capital Management, LLC: 5.8% (Schedule 13G, filed Aug 13, 2026)
- STATE STREET CORPORATION: 5.1% (Schedule 13G, filed May 12, 2026)
Who owns the most VNDA stock?
The largest institutional holders of Vanda Pharmaceuticals Inc. in the latest 13F filings are BlackRock, Inc. (BLK) ($46.8M), VANGUARD GROUP INC ($32.9M), STATE STREET CORP (STT, STT-PG) ($21.5M).
Are insiders buying or selling VNDA?
Over the last 12 months insiders bought $0 and sold $2.82M of Vanda Pharmaceuticals Inc. stock on the open market (SEC Form 4).
Which famous investors own VNDA?
Renaissance Technologies, Two Sigma, Izzy Englander, Ken Griffin.
What was VNDA's revenue last quarter?
Vanda Pharmaceuticals Inc. reported revenue of $50.5M for the quarter ended June 30, 2026, with net income of −$62.5M.
Which ETFs hold VNDA?
5 ETFs and mutual funds hold it among their top 100 positions, including SBIO, FTMSX, MEDX, ASD.